Abstract
Human herpesvirus 6B (HHV-6B) frequently reactivates after cord blood transplantation (CBT). We previously reported an association between HHV-6B reactivation and delirium after hematopoietic cell transplantation. In this prospective study, 35 CBT recipients underwent twice-weekly plasma PCR testing for HHV-6 and thrice-weekly delirium assessment until day 84. There was a quantitative association between HHV-6B reactivation and delirium in univariable (odds ratio, 2.88; 95% confidence interval (CI), 0.97–8.59) and bivariable models. In addition, intensified prophylaxis with high-dose valacyclovir mitigated HHV-6B reactivation (adjusted hazard ratio, 0.39; 95% CI, 0.14–1.08). Larger trials are needed to explore the utility of HHV-6B prophylaxis after CBT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ogata M, Satou T, Kadota J-I, Saito N, Yoshida T, Okumura H et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 2013; 57: 671–681.
Hill J a, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant 2012; 18: 1638–1648.
Chevallier P, Hebia-Fellah I, Planche L, Guillaume T, Bressolette-Bodin C, Coste-Burel M et al. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant 2010; 45: 1204–1211.
Olson AL, Dahi PB, Zheng J, Devlin SM, Lubin M, Gonzales AM et al. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biol Blood Marrow Transplant 2014; 20: 787–793.
Zerr DM, Fann JR, Breiger D, Boeckh M, Adler AL, Xie H et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011; 117: 5243–5249.
Clark D a, Nacheva EP, Leong HN, Brazma D, Li YT, Tsao EHF et al. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 2006; 193: 912–916.
Milano F, Pergam S a, Xie H, Leisenring WM, Gutman J a, Riffkin I et al. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood 2011; 118: 5689–5696.
Trzepacz PT, Baker RW, Greenhouse J . A symptom rating scale for delirium. Psychiatry Res 1988; 23: 89–97.
American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC 2000.
Basinski JR, Alfano CM, Katon WJ, Syrjala KL, Fann JR . Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biol Blood Marrow Transplant 2010; 16: 824–831.
Liang BYK, Zeger SL . Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13–22.
Safdar A, Rodriguez GH, De Lima MJ, Petropoulos D, Chemaly RF, Worth LL et al. Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore) 2007; 86: 324–333.
Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P . HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant 2013; 48: 574–580.
Hill JA, Boeckh MJ, Sedlak RH, Jerome KR, Zerr DM . Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. J Clin Virol 2014; 61: 289–292.
Cassiani-Ingoni R, Greenstone HL, Donati D, Fogdell-Hahn A, Martinelli E, Refai D et al. CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion. Glia 2005; 52: 252–258.
He J, McCarthy M, Zhou Y, Chandran B, Wood C . Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996; 70: 1296–1300.
Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612–619.
Fotheringham J, Akhyani N, Vortmeyer A, Donati D, Williams E, Oh U et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007; 195: 450–454.
Fujita A, Ihira M, Suzuki R, Enomoto Y, Sugiyama H, Sugata K et al. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients. J Infect 2008; 57: 241–248.
Ichiyama T, Ito Y, Kubota M, Yamazaki T, Nakamura K, Furukawa S . Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev 2009; 31: 731–738.
Sobbi SC, van den Boogaard M . Inflammation biomarkers and delirium in critically ill patients: new insights? Crit Care 2014; 18: 153.
Wang L-R, Dong L-J, Lu D-P . Surveillance of active human herpesvirus 6 infection in chinese patients after hematopoietic stem cell transplantation with 3 different methods. Int J Hematol 2006; 84: 262–267.
Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P . Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615–3620.
Ogata M, Satou T, Inoue Y, Takano K, Ikebe T, Ando T et al. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis. Bone Marrow Transplant 2012; 48: 257–264.
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 2013; 369: 1227–1236.
De Pagter PJ, Schuurman R, de Vos NM, Mackay W, van Loon AM . Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. J Clin Microbiol 2010; 48: 2536–2540.
Acknowledgements
We thank the patients and their families who participated in this study, without whose patience and dedication this study could not have been undertaken. This work was supported by the National Institutes of Health (grant numbers R01 AI057639-05S1, DMZ; CA018029 and K24 HL093294, MB). The funding source had no involvement in the study design, collection, analysis and interpretation of data. Ethical approval: all patients provided written consent, and the protocol was approved by the Fred Hutchinson Cancer Research Center Institutional Review Board.
Author contributions
DMZ, MB, JAH, ALA, M-LH, JRF, CD and WML participated in the study design, data analysis and interpretation, and critical review of the report; JH wrote the first draft and all revisions of the report; and HX and WML performed the statistical analyses and participated in revision of the report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
MB received research funding for clinical trials and consulting fees from Chimerix Inc., Genentech/Roche and Gilead in addition to consulting for Clinigen. DMZ received research funding from Chimerix Inc. All other authors report no potential conflicts.
Additional information
Presented in poster form at IDWeek 2014, Philadelphia, PA. 2014: Abstract 45379.
Rights and permissions
About this article
Cite this article
Hill, J., Boeckh, M., Leisenring, W. et al. Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation. Bone Marrow Transplant 50, 1348–1351 (2015). https://doi.org/10.1038/bmt.2015.154
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.154
This article is cited by
-
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study
International Journal of Hematology (2024)
-
Human herpesvirus 6B infection in mesial temporal lobe epilepsy: a meta-analysis
Acta Epileptologica (2022)
-
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Journal of NeuroVirology (2017)